Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Jul 14, 2020 11:42PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Last week it was 2.00US and just now showing 0.00.